Literature DB >> 1721451

Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum.

K Abu-Elmagd1, B V Jegasothy, C D Ackerman, A W Thomson, H Rilo, N Nikolaidis, D Van Thiel, J J Fung, S Todo, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721451      PMCID： PMC3018878     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  "Streaking leukocyte factor," arthritis, and pyoderma gangrenosum.

Authors:  J C Jacobs; E J Goetzl
Journal:  Pediatrics       Date:  1975-10       Impact factor: 7.124

2.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066
  2 in total
  7 in total

Review 1.  FK 506 and autoimmune disease: perspective and prospects.

Authors:  A W Thomson; T E Starzl
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

Review 2.  The role of tacrolimus in inflammatory bowel disease: a systematic review.

Authors:  Yago Gonzalez-Lama; Javier P Gisbert; Jose Mate
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 3.  FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.

Authors:  A W Thomson; P B Carroll; J McCauley; J Woo; K Abu-Elmagd; T E Starzl; D H Van Thiel
Journal:  Springer Semin Immunopathol       Date:  1993

4.  [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].

Authors:  L Trémezaygues; R Schmaltz; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

5.  Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506).

Authors:  K Abu-Elmagd; D H Van Thiel; B V Jegasothy; J C Jacobs; P Carroll; H Rodriquez-Rilo; C D Ackerman; J J Fung; T E Starzl
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

6.  FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice.

Authors:  F Furukawa; S Imamura; M Takigawa
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 7.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.